Alva Health’s mission is to help older Americans living with high stroke risk to prevent disability, live independently, and to bring peace of mind to their families.


Nearly 700,000 Americans suffer an ischemic stroke each year

IV tissue plasminogen activator (tPA) has been an FDA approved therapy since 1995, yet only 5-10% of eligible patients receive this therapy due to delays in seeking medical attention

Despite massive public health campaigns, identifying symptoms of stroke and activating emergency response systems remains a major challenge

Alva Health is developing a better solution